ClinicalTrials.Veeva

Menu

The Safety and Effectiveness of Taneasy and Actein in COPD Patients

B

Bun Yao Biotechnology Co., Ltd

Status and phase

Invitation-only
Phase 4

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Treatments

Drug: Actein effervescent 600mg
Drug: Taneasy 600mg granules

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT06688292
BCQ230209TC

Details and patient eligibility

About

To evaluate the safety and efficacy of Taneasy 600mg granules and Actein effervescent tablets 600MG administered twice daily for 14 days in treatment of COPD Disease.

Full description

The study will enroll 40~60 patients and complete 40 patients.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subjects aged older than 20~75 years old.
  2. Able to sign informed consent prior to the study.
  3. Subjects have COPD.

Exclusion criteria

  1. Subjects with known hypersensitivity to Acetylcysteine preparations.
  2. Subjects with other serious medical diseases that are judged by the attending physician to affect the evaluation results (such as: tuberculosis, pneumonia, bronchial asthma, bronchiectasis, cor pulmonale, lung cancer, acute myocardial infarction, acute hepatitis, renal failure, etc.)
  3. Pregnancy or breast-feeding woman.
  4. Female subjects or their sexual partners do not use contraception during the trial.
  5. Joining any drug clinical trial within 3 months prior to dosing.
  6. Investigator considered to be inappropriate for enrollment.
  7. Phenylketonuria (PKU).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Taneasy 600mg granules
Experimental group
Description:
Dose: 600 mg/time. Use :two times per day.
Treatment:
Drug: Taneasy 600mg granules
Actein effervescent tablets 600MG
Active Comparator group
Description:
Dose: 600 mg/time. Use :two times per day
Treatment:
Drug: Actein effervescent 600mg

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems